shadow_tr

People

Faculty


Mishra

Anil Mishra, PhD

Dr. Anil Mishra, PhD is Professor of Medicine and Endowed Chair, Edward G. Schlieder Educational Foundation and Director of Tulane Eosinophilic Disorder Center in the Section of Pulmonary Diseases, Tulane School of Medicine, New Orleans, LA. Earlier, Dr. Mishra served as a faculty member at Allergy and Immunology Division, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH and Case Western Reserve University Medical College, OH before joining Tulane University School of Medicine, New Orleans, LA.

Dr. Mishra's most important contribution was to establish that eosin are the resident cell that home prenatally in the gastrointestinal tract (Mishra et al. J. Clin. Invest. 1999, 103, 1719-27) and the gastrointestinal tract (esophagus to colon) constitutively expresses certain eotaxin-1 (an eosinophil selective chemoattractant). Dr. Mishra developed a first murine model of asthma associated eosinophilic esophagitis (Mishra et al. J. Clin. Invest. 2001, 107, 83-90). His findings implicated aeroallergen in the etiology of EoE and suggested that esophageal eosinophilic inflammation is mechanistically associated with pulmonary inflammation (Mishra et al. J. Immunology 2002, 168, 2464-69 and Gastroenterology, 2003, 125. 1419-27).

Dr. Mishra is an elected fellow of the American Academy of Allergy Asthma Immunology (FAAAAI), and American Gastrointestinal Association (FAGA). He has over a 65 articles, book chapters and reviews on molecular mechanisms of the pulmonary and gastrointestinal toxicity and allergic responses in high impact factor journals. Some of his publications are cited more than 300 to 400 till 2013. Dr. Mishra's research has been supported by the 2-different intimates of National Institutes of Health (NIDDK and NIAID) to understand the mechanism that induce EoE. He is serving in a number of study sections as member in NIH. More recently, his research implicated iNKT cells to the food and indoor insect allergens induce EoE and NKT cell neutralization as a possible future therapy of EoE (Clinical and Translational Immunology, 2013). He patents IL-15 responsive T cell associated molecules as a non-invasive biographers for EoE that differentiate EoE from GERD. Current interest is on the role of IL-15and IL-18 in pulmonary and gastrointestinal eosin inflammation and rIL-15 treatment strategy for airway hyperactivity and lung or other tissue fibrosis.

If interested in his research publications, grants, awards and honors go to the awards then please go to his Publication list and visit the Webster of Dr. Mishra's Research Laboratory and Tulane Eosinophilic Disorder Center.



1430 Tulane Ave, New Orleans, LA 70112 504-988-5263 medsch@tulane.edu